PT  - JOURNAL ARTICLE
ED  - ,
TI  - Clarification: post-coital contraception (January 18, p 5)
AID  - 10.1136/dtb.18.4.16
DP  - 1980 Feb 15
TA  - Drug and Therapeutics Bulletin
PG  - 16--16
VI  - 18
IP  - 4
4099  - http://dtb.bmj.com/content/18/4/16.short
4100  - http://dtb.bmj.com/content/18/4/16.full
SO  - Drug Ther Bull1980 Feb 15; 18
AB  - Wyeth have asked us to point out that the product licence for Ovran does not allow its use in post-coital contraception, and that such use is not recommended by the company. This applies equally to Schering’s Eugynon 50.